ConcertAI Precision Suite
ConcertAI's Precision Suite is an AI-powered platform designed to accelerate oncology innovation by integrating real-world data with advanced analytics. Powered by the CARA™ platform and Precision360™, it offers tailored solutions for research, clinical trials, and commercialization, enabling life sciences organizations to derive actionable insights, optimize trial designs, and enhance market strategies.
Key Features and Functionality:
- Precision Explorer: A generative AI application that allows Health Economics and Outcomes Research (HEOR), medical, and epidemiology teams to perform dynamic cohort creation, outcomes analysis, and obtain citation-backed insights without programming. This facilitates rapid hypothesis validation and continuous evidence generation in oncology.
- Precision Trials: A SaaS solution that integrates real-world data with generative AI to design, evaluate, and adapt clinical trial strategies efficiently. It helps reduce costly amendments, avoid underperforming sites, and meet diversity and enrollment goals by enabling data-driven, agile trial design and operations.
- Precision GTM: An out-of-the-box SaaS solution that unifies fragmented data sources—including electronic health records (EHR), claims, and social determinants of health—into a single platform tailored for oncology commercialization. It provides rich clinical context, near real-time data updates, and built-in generative AI to support faster decision-making and strategic execution.
Primary Value and User Solutions:
The Precision Suite addresses the challenges of fragmented data and slow, manual processes in oncology research and development. By leveraging AI and real-world data, it enables faster insights, more precise clinical trial designs, and effective market strategies. This leads to improved patient outcomes, reduced costs, and accelerated time-to-market for new therapies. The suite's user-friendly, no-code interfaces ensure accessibility for non-technical users, promoting collaboration and efficiency across teams.
